Should Aerie Pharmaceuticals Inc (AERI) be in Your Portfolio? - InvestorsObserver
Rise in the sentiment of investors in Aerie Pharmaceuticals INC. – Medgazette 24
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharma: Significantly Derisked (NASDAQ:AERI) | Seeking Alpha
Aerie
Eye disease drug firm Aerie Pharma acquires Spanish company for $10M | WRAL TechWire
Aerie-Pharma-Newsletter | OIS
Aerie Pharmaceuticals (AERI) Investor Presentation - Slideshow (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma: Finding Value In The Ophthalmic Space (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma (AERI) Falls on Glaucoma Eye Drop Safety Concerns - TheStreet
Aerie Pharma (AERI) Provides 2020 Company and Guidance Update Associated with COVID-19
Aerie-Pharma -
Aerie Pharmaceuticals Inc - AnnualReports.com
Aerie Pharmaceuticals Launches GMP Facility - Contract Pharma
Compliance Program | Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals to Present at Two Investor Conferences in March | Business Wire
Aerie-Pharma -
Aerie Pharmaceuticals – Capital Sign Solutions
Aerie Pharma appoints Richard Rubino as CFO | Procurement & Supply Chain | Healthcare Global
Cantor Initiates Aerie Pharma At Buy: 'Wouldn't Be Surprised If Aerie Became Takeover Candidate'
Investor Relations | Aerie Pharmaceuticals, Inc
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
